Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 22, 2024CellsOpen Access

Predicting Longitudinal Cognitive Decline and Alzheimer’s Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMin‐Koo ParkJAJinhyun AhnYKYoung-Ju Kim

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Park et al. (2024) studied this question.

synapsesocial.com/papers/68e63aecb6db6435875ccd68https://doi.org/10.3390/cells13131085
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diagnostic and predictive power of plasma proteins in Alzheimer's disease: a cross-sectional and longitudinal study in China2024 · 9 citations
  2. 2Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients2024 · 21 citations
  3. 3Plasma biomarkers predict incident cognitive decline up to 29 years prior to disease onset: a memory clinic cohort study of 4,073 participants2025
  4. 4Incremental value of plasma biomarkers in predicting clinical decline among cognitively unimpaired older adults: Results from the A4 trial2026 · 4 citations
  5. 5Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression2026